AIRLINK 79.41 Increased By ▲ 1.02 (1.3%)
BOP 5.33 Decreased By ▼ -0.01 (-0.19%)
CNERGY 4.38 Increased By ▲ 0.05 (1.15%)
DFML 33.19 Increased By ▲ 2.32 (7.52%)
DGKC 76.87 Decreased By ▼ -1.64 (-2.09%)
FCCL 20.53 Decreased By ▼ -0.05 (-0.24%)
FFBL 31.40 Decreased By ▼ -0.90 (-2.79%)
FFL 9.85 Decreased By ▼ -0.37 (-3.62%)
GGL 10.25 Decreased By ▼ -0.04 (-0.39%)
HBL 117.93 Decreased By ▼ -0.57 (-0.48%)
HUBC 134.10 Decreased By ▼ -1.00 (-0.74%)
HUMNL 7.00 Increased By ▲ 0.13 (1.89%)
KEL 4.67 Increased By ▲ 0.50 (11.99%)
KOSM 4.74 Increased By ▲ 0.01 (0.21%)
MLCF 37.44 Decreased By ▼ -1.23 (-3.18%)
OGDC 136.70 Increased By ▲ 1.85 (1.37%)
PAEL 23.15 Decreased By ▼ -0.25 (-1.07%)
PIAA 26.55 Decreased By ▼ -0.09 (-0.34%)
PIBTL 7.00 Decreased By ▼ -0.02 (-0.28%)
PPL 113.75 Increased By ▲ 0.30 (0.26%)
PRL 27.52 Decreased By ▼ -0.21 (-0.76%)
PTC 14.75 Increased By ▲ 0.15 (1.03%)
SEARL 57.20 Increased By ▲ 0.70 (1.24%)
SNGP 67.50 Increased By ▲ 1.20 (1.81%)
SSGC 11.09 Increased By ▲ 0.15 (1.37%)
TELE 9.23 Increased By ▲ 0.08 (0.87%)
TPLP 11.56 Decreased By ▼ -0.11 (-0.94%)
TRG 72.10 Increased By ▲ 0.67 (0.94%)
UNITY 24.82 Increased By ▲ 0.31 (1.26%)
WTL 1.40 Increased By ▲ 0.07 (5.26%)
BR100 7,526 Increased By 32.9 (0.44%)
BR30 24,650 Increased By 91.4 (0.37%)
KSE100 71,971 Decreased By -80.5 (-0.11%)
KSE30 23,749 Decreased By -58.8 (-0.25%)
World

Canada's Trudeau says Pfizer vaccine results 'promising'

  • Canada signed a deal with US giant Pfizer and its German partner BioNTech in August for a minimum of 20 million doses of their vaccine.
Published November 9, 2020

OTTAWA: Prime Minister Justin Trudeau said Monday he was encouraged by Pfizer and BioNTech's announcement that their Covid-19 vaccine in trials proved 90 percent effective, adding it could be available in Canada in early 2021.

The two pharmaceutical companies said the vaccine they have jointly developed had during Phase 3 trials provided protection to nearly all patients seven days after the second of two vaccine doses.

At a news conference, Trudeau called the results "promising." "We see the light at the end of the tunnel," he said.

The prime minister said he expects the vaccine to be distributed to Canadians "most likely in the first three months of 2021."

"But," he added, "there is a lot of uncertainty involved in these processes."

Canada signed a deal with US giant Pfizer and its German partner BioNTech in August for a minimum of 20 million doses of their vaccine.

It was at the time the most advanced vaccine candidate in development among several of which Canada secured access.

Other agreements were signed with AstraZeneca, Sanofi and GSK, Novavax, Johnson & Johnson, Medicago and Moderna for a total of more than 300 million doses for its population of 38 million.

Trudeau noted that the Pfizer-BioNTech vaccine poses some "logistical distribution" challenges, including that it must be stored at very cold temperatures and therefore getting it to Canadians will be "more complex and slightly more limiting."

"We are already working on those necessary logistical supports," he said.

Trudeau also said that testing of several other vaccine candidates was "progressing well" and some of those could be rolled out in early 2021 too.

Until then, he encouraged Canadians to continue to take precautions to limit the spread of the Covid-19 illness, including social distancing and wearing masks.

As of Monday, Canada has reported more than 260,000 Covid-19 infections, including 10,500 deaths.

"To be very clear: If you catch Covid in the coming days and weeks, a vaccine won't help you or your family," Trudeau concluded.

Comments

Comments are closed.